Last: | $19.5503 |
---|---|
Change Percent: | 0.52% |
Open: | $19.55 |
Close: | $19.45 |
High: | $19.61 |
Low: | $19.5 |
Volume: | 37,907 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$19.5503 | $19.55 | $19.45 | $19.61 | $19.5 | 37,907 | 04-26-2024 |
$19.45 | $19.41 | $19.45 | $19.5 | $19.28 | 34,115 | 04-25-2024 |
$19.57 | $19.62 | $19.57 | $19.64 | $19.42 | 88,137 | 04-24-2024 |
$19.61 | $19.47 | $19.61 | $19.68 | $19.39 | 63,368 | 04-23-2024 |
$19.42 | $19.09 | $19.42 | $19.44 | $19.05 | 70,353 | 04-22-2024 |
$18.99 | $18.93 | $18.99 | $19.16 | $18.93 | 56,116 | 04-19-2024 |
$18.88 | $18.85 | $18.88 | $18.977 | $18.81 | 47,798 | 04-18-2024 |
$18.81 | $18.58 | $18.81 | $18.89 | $18.55 | 94,736 | 04-17-2024 |
$18.52 | $18.49 | $18.52 | $18.58 | $18.28 | 94,410 | 04-16-2024 |
$18.49 | $18.97 | $18.49 | $19.03 | $18.38 | 121,683 | 04-15-2024 |
$18.91 | $19.08 | $18.91 | $19.15 | $18.84 | 62,389 | 04-12-2024 |
$19.07 | $19.2 | $19.07 | $19.251 | $18.95 | 90,489 | 04-11-2024 |
$19.17 | $19.42 | $19.17 | $19.42 | $19.08 | 68,625 | 04-10-2024 |
$19.522 | $19.5021 | $19.522 | $19.5518 | $19.4426 | 81,249 | 04-09-2024 |
$19.52 | $19.42 | $19.52 | $19.57 | $19.4 | 81,033 | 04-08-2024 |
$19.4 | $19.31 | $19.4 | $19.4 | $19.18 | 106,556 | 04-05-2024 |
$19.39 | $19.66 | $19.39 | $19.68 | $19.27 | 96,053 | 04-04-2024 |
$19.52 | $19.55 | $19.52 | $19.64 | $19.46 | 93,662 | 04-03-2024 |
$19.64 | $19.57 | $19.64 | $19.68 | $19.5316 | 52,098 | 04-02-2024 |
$19.65 | $19.65 | $19.65 | $19.66 | $19.5201 | 96,274 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest Company Name:
HTD Stock Symbol:
NYSE Market:
MENLO PARK, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of t...
MENLO PARK, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of th...
2024-04-09 09:00:15 ET John Hancock Tax- Advantaged Dividend Income (HTD) declaring a stock dividend of $0.138 per share on Ex-Date : April 10, 2024. Shareholders on record as of April 11, 2024 are eligible for the dividend. The payment date is scheduled for April 30, 2024, and the ...